Skip to main content
$1.53 +0.01 (+0.33%) At close · Jul 27
Market Cap
$6.43M
Shares
4.20M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.53 Open$1.52 Day$1.48–1.59 52W$1.48–8.19 Avg vol 30d181K Short int18K · 0.4% float · 1.0d Short vol45% Last earningsMay 12, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 12

Up next

Next earnings call
Aug 13, 2026 Est · unconfirmed · in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 12, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 18.7 · elevated Equity put/call 0.66
      Technical
      price trend
      Strong Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −52%
      below
      Price vs 50-day avg −23%
      below
      RSI (14) 28
      oversold
      MACD trend Negative
      52-week position 1%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −11%
      trailing
      6-month return −54%
      trailing
      YTD return −60%
      this year
      Relative strength −61%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $2 › 200d $3 — 200d above 50d
      Institutional flow Flat
      2 of 19 funds reported for Jun 30 · net 0 sh shares
      Insider flow Distributing
      Net -$26.2K over 90 days · 100% sells
      Short interest Falling
      0.44% of float · ▼ -63.9% MoM · 1.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      19 holders — mid 1-yr range
      Squeeze score 27
      low risk · 0–100
      Fundamentals
      Strong
      Revenue growth 0%
      Y/Y
      EPS growth +60%
      Y/Y
      Free cash flow $-14.2M
      Balance sheet $2.8M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 55%
      annualized · 1-yr
      Max drawdown −81%
      past year
      ATR 10.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Technicals

      trend & momentum for long-term holders Strong Sell
      4 · 3 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −52% Bearish
      Price vs 50-day avg
      −23% Bearish
      RSI (14)
      28 Neutral
      MACD trend
      Negative Bearish
      52-week position
      1% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $2 › 200d $3 — 200d above 50d
      Institutional flow Flat
      2 of 19 funds reported for Jun 30 · net 0 sh shares
      Insider flow Distributing
      Net -$26.2K over 90 days · 100% sells
      Short interest Falling
      0.44% of float · ▼ -63.9% MoM · 1.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      19 holders — mid 1-yr range
      Price context
      position in its 52-week range
      52-wk low $1 Now $2 · 1% 52-wk high $8
      vs 200-day avg -52% vs 50-day avg -23%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      IMNN
      Imunon, Inc.
      this stock
      $6.43M -59.8% +0.0% 0.4%
      ONC
      BeOne Medicines Ltd.
      $471.01B +7.3% +22179.2% 958.5 0.1%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      $121.57B +5.7% +46.2% 28.4 2.0%
      REGN
      Regeneron Pharmaceuticals, Inc.
      $69.95B -13.5% +20.8% 16.3 3.3%
      ARGX
      Argenx SE
      $55.61B +5.7% 2.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders
      Holders
      19
      % held
      12.0%
      Reported
      2 of 19
      Top holder
      ARMISTICE CAPITAL, LLC
      Held Float
      View
      Held by Funds
      Fund positions
      6
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      18.4K
      Days to cover
      1.0d
      Change
      -32.6K sh
      View
      Short Volume
      Short vol %
      45%
      As of
      Jul 27, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      149
      Value
      $265
      As of
      Jun 24, 2026
      View
      Off-Exchange
      Off-exchange %
      45.2%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$26.2K
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $500.0K
      Net income (FY)
      $-14.5M
      EPS diluted
      $-6.83
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 30, 2026
      This year
      12
      View
      Exempt Offerings
      Offering
      $3.3M
      Filed
      May 28, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 12, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      IMNN -16.4% -11.1% -53.9% -14.0% -59.8%
      SPY -0.6% +0.7% +6.8% -1.0% +8.4%
      vs SPY -15.8% -11.7% -60.7% -13.0% -68.2%
      Key facts CIK 749647 CUSIP 15117N701 13F (30d) 2 filings 2 filers Visit website Investor relations